- US-listed companies
- FILANA THERAPEUTICS, INC.
- Income statement
FILANA THERAPEUTICS, INC.【FLNA】Income statement
Market cap
$106.76M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 11 | 11 | 41 | - | - | - | - | - | - | - | - | - | - | - |
| Revenue growth (%) | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Research & development | 8 | 8 | 5 | 7 | 9 | 9 | 8 | 3 | - | - | - | - | 89 | 70 |
| Operating margin (%) | - | - | - | - | - | - | - | - | - | - | - | |||
| Operating expenses | 15 | 15 | 10 | 12 | 14 | 15 | 12 | 7 | 5 | 6 | 33 | 80 | 106 | 141 |
| Operating income | -4 | -4 | 31 | -12 | -14 | -15 | -12 | -7 | -5 | -6 | -33 | -80 | -106 | -141 |
| Income before tax | -3 | - | 31 | -12 | -14 | - | - | - | - | - | - | - | - | - |
| Pretax margin (%) | -22.8 | - | 76.5 | - | - | - | - | - | - | - | - | - | - | - |
| Provision for income taxes | - | - | -0 | - | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| Net income | -3 | -3 | 32 | -12 | -14 | -15 | -12 | -7 | -5 | -6 | -32 | -76 | -97 | -24 |
| Net income margin (%) | - | - | - | - | - | - | - | - | - | - | - | |||
| Earnings per share | - | - | 0.7 | -0.27 | -0.31 | - | - | - | - | - | - | - | -2.32 | -0.53 |
| Diluted EPS | - | - | 0.7 | -0.27 | -0.31 | - | - | - | - | - | - | - | -2.32 | -1.46 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | |||
| EBITDA margin (%) | - | - | - | - | - | - | - | - | - | - | - | - |